Biotech & Bioprocessing

Will Dental Soft-Tissue Regeneration Reach $0.53 Billion by 2030?
Biotech & Bioprocessing Will Dental Soft-Tissue Regeneration Reach $0.53 Billion by 2030?

The dental soft-tissue regeneration market is on the cusp of a significant transformation. This sector is poised to reach a staggering valuation of $0.53 billion by the decade's close, with a robust compound annual growth rate of 6.8%. This promising trajectory is largely fueled by a rise in the

Can Engineering and Immunotherapy Revolutionize Cancer Care?
Biotech & Bioprocessing Can Engineering and Immunotherapy Revolutionize Cancer Care?

Cancer treatment, long considered a formidable challenge, has seen significant advancements with the collaboration of engineering and biomedical sciences. The Cancer Bioengineering Collaborative represents a milestone in merging these disciplines to revolutionize cancer diagnosis, monitoring, and

University of Michigan Tightens Policies After Smuggling Arrests
Biotech & Bioprocessing University of Michigan Tightens Policies After Smuggling Arrests

The University of Michigan finds itself in the spotlight as it reviews its internal policies in response to alarming incidents involving biohazardous materials. Recently, two Chinese nationals affiliated with the institution were arrested for attempting to smuggle these materials into the United

TRACE: Revolutionizing Bioprinting With Collagen Innovations
Biotech & Bioprocessing TRACE: Revolutionizing Bioprinting With Collagen Innovations

In the rapidly advancing field of biofabrication, a groundbreaking technique has emerged from a team of scientists at the Renaissance School of Medicine at Stony Brook University. This innovation, known as TRACE (Tunable Rapid Assembly of Collagenous Elements), signifies a major leap forward in

Is CASGEVY the Future of Gene Therapy for Sickle Cell?
Biotech & Bioprocessing Is CASGEVY the Future of Gene Therapy for Sickle Cell?

With the development of gene therapies in the treatment of genetic disorders, the recent advances made by CRISPR Therapeutics draw significant attention. The emergence of their flagship therapy, CASGEVY, presents a promising alternative, particularly for sickle cell disease. Sickle cell disease, a

UBC Scientists Innovate AI and 3D Bioprinting for Male Infertility
Biotech & Bioprocessing UBC Scientists Innovate AI and 3D Bioprinting for Male Infertility

Male infertility is an emotional and complex issue affecting numerous individuals and couples worldwide, posing significant medical challenges. One of the significant contributors to this challenge is non-obstructive azoospermia (NOA), a severe condition where men produce little or no sperm. Recent

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later